Eliana Merle
Stock Analyst at Barclays
(1.40)
# 3,663
Out of 5,090 analysts
440
Total ratings
40.8%
Success rate
-0.2%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Eliana Merle
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| PTCT PTC Therapeutics | Maintained: Buy | $122 | $59.97 | +103.44% | 16 | Nov 2, 2026 | |
| INSM Insmed | Maintained: Buy | $207 | $112.58 | +83.87% | 10 | Nov 2, 2026 | |
| BBIO BridgeBio Pharma | Maintained: Buy | $156 | $74.95 | +108.14% | 24 | Nov 2, 2026 | |
| ALNY Alnylam Pharmaceuticals | Maintained: Buy | $450 → $380 | $165.00 | +130.30% | 19 | Oct 30, 2026 | |
| KYMR Kymera Therapeutics | Reiterated: Buy | $139 → $170 | $126.63 | +34.25% | 13 | Oct 30, 2026 | |
| MRNA Moderna | Reiterated: Hold | $125 | $221.72 | -43.62% | 34 | Oct 26, 2026 | |
| TYRA Tyra Biosciences | Reiterated: Buy | $59 | $21.07 | +180.02% | 11 | Oct 26, 2026 | |
| BMRN BioMarin Pharmaceutical | Reiterated: Buy | $111 → $114 | $58.51 | +94.84% | 43 | Oct 13, 2026 | |
| FDMT 4D Molecular Therapeutics | Reiterated: Buy | $28 | $11.90 | +135.29% | 3 | Oct 13, 2026 | |
| MBX MBX Biosciences | Reiterated: Buy | $88 | $55.87 | +57.51% | 7 | Oct 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $12 | $7.20 | +66.67% | 7 | Oct 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Sell | $8 | $12.47 | -35.85% | 1 | Oct 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $60 → $28 | $24.83 | +12.77% | 15 | Oct 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $917 | $927.89 | -1.17% | 6 | Oct 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $329 | $251.27 | +30.93% | 15 | Sep 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $962 | $430.36 | +123.53% | 16 | Sep 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $617 | $558.88 | +10.40% | 17 | Sep 23, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $85 | $43.52 | +95.31% | 25 | Sep 18, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $32 → $35 | $16.10 | +117.39% | 8 | Sep 18, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $8 → $18 | $9.92 | +81.45% | 5 | Sep 9, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $20 | $2.04 | +880.39% | 8 | Aug 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $13 | $3.35 | +288.06% | 2 | Aug 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $20 | $18.62 | +7.41% | 12 | Aug 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | $22 | $10.38 | +115.80% | 14 | Jul 28, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $18 | $3.65 | +393.15% | 4 | Jun 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $115 → $117 | $88.17 | +32.70% | 25 | Nov 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $33 → $20 | $48.28 | n/a | 25 | Aug 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $96 → $112 | $170.68 | n/a | 3 | Aug 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $63 → $12 | $59.90 | n/a | 3 | Jul 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $8 | $1.30 | n/a | 1 | Jul 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $74 → $21 | $7.86 | n/a | 12 | May 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $5 → $2.2 | $1.96 | n/a | 6 | Jan 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $71 | $191.31 | n/a | 1 | Jan 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $3 → $5 | $99.18 | n/a | 3 | Apr 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $22 | $10.76 | n/a | 1 | Oct 13, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $10 | $6.49 | n/a | 3 | Mar 3, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $192 → $134 | $32.28 | n/a | 10 | Aug 19, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $40 | $1.39 | n/a | 8 | Dec 11, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $8 | $3.24 | n/a | 4 | Mar 18, 2019 |
PTC Therapeutics
Nov 2, 2026
Maintained: Buy
Price Target: $122
Current: $59.97
Upside: +103.44%
Insmed
Nov 2, 2026
Maintained: Buy
Price Target: $207
Current: $112.58
Upside: +83.87%
BridgeBio Pharma
Nov 2, 2026
Maintained: Buy
Price Target: $156
Current: $74.95
Upside: +108.14%
Alnylam Pharmaceuticals
Oct 30, 2026
Maintained: Buy
Price Target: $450 → $380
Current: $165.00
Upside: +130.30%
Kymera Therapeutics
Oct 30, 2026
Reiterated: Buy
Price Target: $139 → $170
Current: $126.63
Upside: +34.25%
Moderna
Oct 26, 2026
Reiterated: Hold
Price Target: $125
Current: $221.72
Upside: -43.62%
Tyra Biosciences
Oct 26, 2026
Reiterated: Buy
Price Target: $59
Current: $21.07
Upside: +180.02%
BioMarin Pharmaceutical
Oct 13, 2026
Reiterated: Buy
Price Target: $111 → $114
Current: $58.51
Upside: +94.84%
4D Molecular Therapeutics
Oct 13, 2026
Reiterated: Buy
Price Target: $28
Current: $11.90
Upside: +135.29%
MBX Biosciences
Oct 13, 2026
Reiterated: Buy
Price Target: $88
Current: $55.87
Upside: +57.51%
Oct 13, 2026
Reiterated: Hold
Price Target: $12
Current: $7.20
Upside: +66.67%
Oct 7, 2026
Initiated Coverage: Sell
Price Target: $8
Current: $12.47
Upside: -35.85%
Oct 6, 2026
Downgraded: Hold
Price Target: $60 → $28
Current: $24.83
Upside: +12.77%
Oct 2, 2026
Reiterated: Buy
Price Target: $917
Current: $927.89
Upside: -1.17%
Sep 30, 2026
Reiterated: Buy
Price Target: $329
Current: $251.27
Upside: +30.93%
Sep 30, 2026
Reiterated: Buy
Price Target: $962
Current: $430.36
Upside: +123.53%
Sep 23, 2026
Reiterated: Buy
Price Target: $617
Current: $558.88
Upside: +10.40%
Sep 18, 2026
Reiterated: Buy
Price Target: $85
Current: $43.52
Upside: +95.31%
Sep 18, 2026
Reiterated: Buy
Price Target: $32 → $35
Current: $16.10
Upside: +117.39%
Sep 9, 2026
Upgraded: Buy
Price Target: $8 → $18
Current: $9.92
Upside: +81.45%
Aug 13, 2026
Reiterated: Buy
Price Target: $20
Current: $2.04
Upside: +880.39%
Aug 7, 2026
Reiterated: Buy
Price Target: $13
Current: $3.35
Upside: +288.06%
Aug 7, 2026
Reiterated: Hold
Price Target: $20
Current: $18.62
Upside: +7.41%
Jul 28, 2026
Reiterated: Sell
Price Target: $22
Current: $10.38
Upside: +115.80%
Jun 4, 2026
Reiterated: Buy
Price Target: $18
Current: $3.65
Upside: +393.15%
Nov 6, 2025
Reiterated: Hold
Price Target: $115 → $117
Current: $88.17
Upside: +32.70%
Aug 12, 2025
Reiterated: Hold
Price Target: $33 → $20
Current: $48.28
Upside: n/a
Aug 8, 2025
Reiterated: Hold
Price Target: $96 → $112
Current: $170.68
Upside: n/a
Jul 21, 2025
Downgraded: Hold
Price Target: $63 → $12
Current: $59.90
Upside: n/a
Jul 15, 2025
Reiterated: Buy
Price Target: $8
Current: $1.30
Upside: n/a
May 15, 2025
Reiterated: Buy
Price Target: $74 → $21
Current: $7.86
Upside: n/a
Jan 28, 2025
Reiterated: Hold
Price Target: $5 → $2.2
Current: $1.96
Upside: n/a
Jan 8, 2025
Reiterated: Buy
Price Target: $71
Current: $191.31
Upside: n/a
Apr 4, 2024
Reiterated: Hold
Price Target: $3 → $5
Current: $99.18
Upside: n/a
Oct 13, 2022
Initiated Coverage: Buy
Price Target: $22
Current: $10.76
Upside: n/a
Mar 3, 2021
Reiterated: Buy
Price Target: $10
Current: $6.49
Upside: n/a
Aug 19, 2020
Reiterated: Hold
Price Target: $192 → $134
Current: $32.28
Upside: n/a
Dec 11, 2019
Reiterated: Buy
Price Target: $40
Current: $1.39
Upside: n/a
Mar 18, 2019
Reiterated: Buy
Price Target: $8
Current: $3.24
Upside: n/a